NIR In-Line Monitoring for Drug Product Continuous Process: From Understanding to Control
Posted on January 29, 2024
Yang (Angela) Liu, Associate Research Fellow (Previously Senior Principal Scientist in the Analytical Development group)
Daniel O. Blackwood, Associate Research Fellow in the Drug Product Design group
Jeffrey Moriarty, Director (Previously Senior Scientist in the Drug Product Design group)
Pfizer, Inc.
Introduction During the past decade, continuous processing has steadily gained traction within pharmaceutical industry. The smaller footprint, the reduction or minimization of technology transfer and overall flexibility of these systems generate the economic drivers for change. The advancement of te...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy
